Beate Betz

1.8k total citations
25 papers, 928 citations indexed

About

Beate Betz is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Beate Betz has authored 25 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Beate Betz's work include Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Epigenetics and DNA Methylation (4 papers). Beate Betz is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Epigenetics and DNA Methylation (4 papers). Beate Betz collaborates with scholars based in Germany, France and China. Beate Betz's co-authors include Dieter Niederacher, Edgar Dahl, Frank Wiesmann, Brigitte Royer‐Pokora, Eva Klopocki, Oumar Camara, Oliver Galm, Matthias Dürst, Glen Kristiansen and Han‐Xiang An and has published in prestigious journals such as Blood, Oncogene and International Journal of Cancer.

In The Last Decade

Beate Betz

23 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beate Betz Germany 16 610 243 224 187 167 25 928
Tim Ripperger Germany 15 341 0.6× 259 1.1× 215 1.0× 135 0.7× 203 1.2× 46 756
Nicolas Goardon France 16 470 0.8× 245 1.0× 223 1.0× 160 0.9× 114 0.7× 29 905
Lalitha Nagarajan United States 20 690 1.1× 175 0.7× 109 0.5× 177 0.9× 143 0.9× 46 1.0k
Holger Kohlhammer Germany 9 393 0.6× 107 0.4× 168 0.8× 203 1.1× 185 1.1× 11 721
Julian Schardt Switzerland 13 468 0.8× 175 0.7× 392 1.8× 369 2.0× 66 0.4× 26 1.1k
Catherine Dubois d’Enghien France 13 528 0.9× 177 0.7× 179 0.8× 264 1.4× 71 0.4× 19 870
Henry Lee-Six United Kingdom 8 566 0.9× 171 0.7× 534 2.4× 362 1.9× 185 1.1× 14 1.1k
Nurten Yigit Belgium 15 577 0.9× 100 0.4× 282 1.3× 264 1.4× 54 0.3× 29 864
Nicola Foot United Kingdom 14 402 0.7× 120 0.5× 113 0.5× 200 1.1× 157 0.9× 25 837
Hyun S. Shvartsman United States 9 355 0.6× 147 0.6× 86 0.4× 194 1.0× 81 0.5× 10 785

Countries citing papers authored by Beate Betz

Since Specialization
Citations

This map shows the geographic impact of Beate Betz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Betz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Betz more than expected).

Fields of papers citing papers by Beate Betz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Betz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Betz. The network helps show where Beate Betz may publish in the future.

Co-authorship network of co-authors of Beate Betz

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Betz. A scholar is included among the top collaborators of Beate Betz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Betz. Beate Betz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elbracht, Miriam, Robert Meyer, Deniz Gezer, et al.. (2021). Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms. Blood Advances. 5(17). 3373–3376. 8 indexed citations
2.
Kuendgen, Andrea, Catharina Müller‐Thomas, Michael Lauseker, et al.. (2018). Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget. 9(45). 27882–27894. 54 indexed citations
3.
4.
Schuler, Esther, Friederike Frank, Barbara Hildebrandt, et al.. (2017). Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML. Leukemia Research. 65. 1–4. 16 indexed citations
5.
Kuendgen, A., Catharina Müller‐Thomas, Michael Lauseker, et al.. (2015). 160 ANALYSIS OF POSSIBLE BIOMARKERS TO PREDICT RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE. Leukemia Research. 39. S82–S82.
6.
Glaser, J, M Neumann, Qi Mei, et al.. (2014). Macrophage Capping Protein CapG Is a Putative Oncogene Involved in Migration and Invasiveness in Ovarian Carcinoma. BioMed Research International. 2014. 1–8. 35 indexed citations
7.
Kuendgen, Andrea, Michael Lauseker, Torsten Haferlach, et al.. (2013). Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes. Blood. 122(21). 2758–2758. 3 indexed citations
8.
9.
Hardt, Karin, Beate Betz, Timm O. Goecke, et al.. (2011). Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies. Familial Cancer. 10(2). 273–284. 22 indexed citations
10.
Betz, Beate, Stephan Theiss, Carolin Konermann, et al.. (2009). Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2. Journal of Cancer Research and Clinical Oncology. 136(1). 123–134. 20 indexed citations
11.
Morak, Monika, Hans Konrad Schackert, Nils Rahner, et al.. (2008). Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. European Journal of Human Genetics. 16(7). 804–811. 79 indexed citations
12.
Engert, Stefanie, Barbara Wappenschmidt, Beate Betz, et al.. (2008). MLPA screening in theBRCA1gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Human Mutation. 29(7). 948–958. 74 indexed citations
13.
Sadr‐Nabavi, Ariane, Juliane Ramser, Jens Volkmann, et al.. (2008). Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. International Journal of Cancer. 124(7). 1727–1735. 79 indexed citations
14.
Versmold, Beatrix, Jörg Felsberg, Thomas Mikeska, et al.. (2007). Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. International Journal of Cancer. 121(3). 547–554. 56 indexed citations
15.
Renz, Malte, Beate Betz, Dieter Niederacher, Hans Bender, & Jörg Langowski. (2007). Invasive breast cancer cells exhibit increased mobility of the actin‐binding protein CapG. International Journal of Cancer. 122(7). 1476–1482. 37 indexed citations
16.
Veeck, Jürgen, Dieter Niederacher, Han‐Xiang An, et al.. (2006). Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene. 25(24). 3479–3488. 213 indexed citations
17.
Huck, Kirsten, Helmut Hanenberg, Sonja Gudowius, et al.. (2006). Delayed diagnosis and complications of Fanconi anaemia at advanced age – a paradigm. British Journal of Haematology. 133(2). 188–197. 24 indexed citations
18.
Betz, Beate, Andrea R. Florl, Hans‐Helge Seifert, et al.. (2004). Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer. Human Mutation. 23(6). 612–620. 14 indexed citations
19.
Dufault, Michael R., Beate Betz, Barbara Wappenschmidt, et al.. (2004). Limited relevance of the CHEK2 gene in hereditary breast cancer. International Journal of Cancer. 110(3). 320–325. 70 indexed citations
20.
Sorg, Rüdiger V., et al.. (2001). The influence of hormones on CD44 expression in endometrial and breast carcinomas. Oncology Reports. 8(5). 987–93. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Ripperger Breakdown of academic impact, for papers by Nicolas Goardon Breakdown of academic impact, for papers by Lalitha Nagarajan Breakdown of academic impact, for papers by Holger Kohlhammer Breakdown of academic impact, for papers by Julian Schardt Breakdown of academic impact, for papers by Catherine Dubois d’Enghien Breakdown of academic impact, for papers by Henry Lee-Six Breakdown of academic impact, for papers by Nurten Yigit Breakdown of academic impact, for papers by Nicola Foot Breakdown of academic impact, for papers by Hyun S. Shvartsman
Rankless by CCL
2026